CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinheiro, S. P.
Right arrow Articles by Hankinson, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinheiro, S. P.
Right arrow Articles by Hankinson, S. E.
Related Collections
Right arrow Epidemiology
Right arrow Epidemiology: Biomarkers
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2147-2153, September 2005
© 2005 American Association for Cancer Research

Racial Differences in Premenopausal Endogenous Hormones

Simone P. Pinheiro1, Michelle D. Holmes2, Michael N. Pollak3, Robert L. Barbieri4 and Susan E. Hankinson1,2

1 Department of Epidemiology, Harvard School of Public Health; 2 Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts; 3 Cancer Prevention Research Unit, Department of Oncology, Jewish General Hospital and McGill University, Montreal, Quebec, Canada; and 4 Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts

Requests for reprints: Simone P. Pinheiro, Channing Laboratory, Harvard Medical School and Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115. E-mail: n2spp{at}channing.harvard.edu

Differences in breast cancer incidence across racial groups are well documented. African Americans have the highest rates of premenopausal breast cancer and Asians have lower breast cancer rates across all age groups. We hypothesized that levels of premenopausal endogenous hormones and growth factors, risk factors that have been predictive of breast cancer, would differ by race. Using a cross-sectional study design, we tested this hypothesis in the Nurses' Health Study II. We assayed estradiol, progesterone, prolactin, sex hormone binding globulin (SHBG), insulin-like growth factor-I (IGF-I), and IGFBP-3 in 111 African American and 111 Asian American women, matched to 111 Caucasian women on age, day of luteal phase, and day, time, and fasting status at blood collection. We analyzed the association between race and hormone levels using robust linear regression methods. In multivariate models, compared with Caucasians, African Americans had 18% higher levels of estradiol (P < 0.01), 17% higher free estradiol (P < 0.01), 11% lower SHBG (P = 0.05), 11% higher IGF-I (P < 0.01), 25% higher free IGF-I (P < 0.01), and 9% lower IGFBP-3 (P < 0.01) levels. In multivariate models, compared with Caucasian women, Asian Americans had 22% higher calculated free estradiol (P < 0.01), 31% lower SHBG (P < 0.01), and 25% higher free IGF-I (P < 0.01) levels. No racial differences were found in progesterone and prolactin levels. Our study showed hormone differences consistent with breast cancer risk between Caucasians and African Americans but inconsistent with breast cancer risk between Asian Americans and Caucasians. Further research is needed to explore differences across racial groups and the link between endogenous hormones and breast cancer risk.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. P. Rose, S. M. Haffner, and J. Baillargeon
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
Endocr. Rev., December 1, 2007; 28(7): 763 - 777.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. R. Forman
Changes in Dietary Fat and Fiber and Serum Hormone Concentrations: Nutritional Strategies for Breast Cancer Prevention over the Life Course
J. Nutr., January 1, 2007; 137(1): 170S - 174S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson
Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.-J. Chen, W.-S. Yang, J.-H. Yang, C. K. Hsiao, Y.-S. Yang, and H.-N. Ho
Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
Hum. Reprod., September 1, 2006; 21(9): 2266 - 2271.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.